Etomidate Market Size

Etomidate Market size was over USD 80.42 billion in 2023 and is anticipated to reach USD 121.12 billion by 2036, witnessing around 3.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of etomidate is estimated at USD 82.48 billion. The growth of the market can be attributed primarily to the increasing demand for effective anesthetic drugs, and growing research and development activities associated with the development of drugs for cardiovascular diseases. Along with these, etomidate is widely used in animal testing and experiments. With the rise in the number of tests being conducted on animals, the demand for the product is expected to witness a surge in the upcoming years. In 2019, the United States alone used more than 790,000 animals for research. Out of these, guinea pigs were used the most, accounting for the largest share of around 25 percent. Furthermore, removal of epileptogenic centers from the brain during speech lateralization also involves deployment of the product, which in turn is projected to offer ample growth opportunities to the market in the near future.